Central sensitization is the amplification of neural signaling within the central nervous system (spinal cord and brain) that produces pain hypersensitivity. In a centrally sensitized state, the gain on the pain system has been turned up: normal inputs produce exaggerated responses, and inputs that should not produce pain at all begin to do so.
The concept was developed by Clifford Woolf in the 1980s through experiments demonstrating that injury-driven input from the periphery could induce lasting changes in spinal cord excitability — changes that persisted after the peripheral input stopped. This was a paradigm shift. It meant that the central nervous system was not a passive relay for peripheral signals but an active processor that could be fundamentally altered by its own experience.
Mechanisms
Central sensitization involves several interacting processes:
- Wind-up — repeated C-fiber stimulation at the same intensity produces progressively larger responses in dorsal horn neurons. The same input generates increasing output — a neural amplification that does not require any change in the peripheral stimulus.
- NMDA receptor activation — under normal conditions, NMDA receptors on dorsal horn neurons are blocked by magnesium ions. Sustained nociceptive input removes this block, allowing calcium influx that triggers intracellular cascades leading to long-term changes in neuronal excitability. This is structurally similar to the long-term potentiation (LTP) involved in learning and memory — the nervous system is literally learning to produce pain more efficiently.
- Expanded receptive fields — dorsal horn neurons begin responding to input from areas beyond their normal receptive field. A neuron that previously responded only to input from the thumb may begin responding to input from the entire hand. This produces the clinical phenomenon of pain spreading beyond the site of original injury.
- Loss of inhibitory interneurons — sustained nociceptive input can damage or suppress inhibitory interneurons in the dorsal horn that normally act as brakes on pain transmission. When these brakes fail, excitatory signals pass through unchecked.
- Glial activation — microglia and astrocytes in the spinal cord become activated by sustained nociceptive input, releasing pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and other mediators that maintain neuronal hyperexcitability. This neuroinflammation can persist long after the original peripheral stimulus has resolved.
Clinical manifestations
Central sensitization produces recognizable clinical features:
- Allodynia — pain from stimuli that are not normally painful (light touch, gentle pressure, mild temperature changes)
- Hyperalgesia — increased pain from stimuli that are normally painful (a mildly painful pinch produces severe pain)
- Temporal summation — repeated identical stimuli at the same intensity produce progressively increasing pain
- Expanded pain distribution — pain that spreads beyond the site of original injury or develops in areas remote from any identifiable pathology
- After-sensations — pain that persists or intensifies after the stimulus is removed
These features are present across many chronic pain conditions: fibromyalgia, chronic low back pain, chronic tension-type headache, temporomandibular disorders, irritable bowel syndrome, and chronic pelvic pain syndromes. The conditions differ in their peripheral triggers but share central sensitization as a maintaining mechanism.
Implications for treatment
If central sensitization is the mechanism sustaining chronic pain, then treatments targeting peripheral tissue alone will be insufficient. The target must include the sensitized central nervous system itself:
- Neuroplasticity-based approaches — somatic practices that retrain the nervous system’s processing of sensation (graded motor imagery, mirror therapy, somatic awareness training) address the cortical and spinal components of sensitization
- Descending modulation — exercise, sleep optimization, stress reduction, and mindfulness-based interventions can shift descending modulation from facilitation back toward inhibition
- Pharmacological modulation — medications targeting central mechanisms (gabapentinoids, SNRIs, NMDA antagonists) rather than peripheral inflammation (NSAIDs) or peripheral nociception (opioids) may be more appropriate for centrally driven pain
- Context modification — because psychosocial factors (stress, isolation, threat perception) drive descending facilitation, addressing these factors is not adjunctive but mechanistically central to treatment
In TCM terms, central sensitization is a state in which Qi stagnation has become self-perpetuating — the system’s operational flow is disrupted not by an ongoing obstruction but by the pattern of disruption itself. The system has learned dysfunction.
Related terms
- Nociception — the peripheral process that central sensitization amplifies and distorts
- Chronic Pain — the clinical condition sustained by central sensitization
- Allodynia — pain from non-noxious stimuli, a cardinal feature
- Hyperalgesia — amplified pain response, another cardinal feature